Global Pain Management Devices Market

Pain Management Devices Market Size, Share, Growth Analysis, By Type(Neurostimulation Device (TENS, and Spinal Cord Stimulation), Ablation Devices (RF Ablation Device and Cryoablation), Infusion Pumps (Intrathecal Infusion Pumps), By Mode of Purchase(Prescription, and Over the Counter), By Application(Cancer Pain, Neuropathic Pain, Facial Pain & Migraine, Musculoskeletal Pain), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2502 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 67 | Figures: 75

Pain Management Devices Market Competitive Landscape

To increase their market penetration, key vendors are continually engaged in the strategic efforts such as the technology innovation, partnerships, geographical expansion, and mergers and acquisitions. For instance, Medtronic announced the commercial introduction of the InterStim Micro Neurostimulator, a neurostimulator that has received FDA approval, in August 2020. The device was designed to aid patients in regaining reliable bladder and bowel control through sacral neuromodulation (SNM) therapy.

Top Player’s Company Profiles in Pain Management Devices Market

  • MEDTRONIC (Ireland)  
  • ABBOTT LABORATORIES (US) 
  • BOSTON SCIENTIFIC CORPORATION (US) 
  • STRYKER CORPORATION (US) 
  • Becton, Dickinson and Company (US) 
  • B. BRAUN MELSUNGEN AG (Germany) 
  • BAXTER INTERNATIONAL INC. (US) 
  • AVANOS MEDICAL, INC. (US) 
  • TELEFLEX, INC. (US) 
  • NIPRO CORPORATION (Japan) 
  • MOOG INC. (US) 
  • ATRICURE (US) 
  • NEVRO CORP. (US) 
  • MINDRAY MEDICAL INTERNATIONAL LIMITED (China) 
  • SHENZHEN MEDRENA BIOTECH CO., LTD. (China) 
  • EPIC MEDICAL (US) 
  • SOTERIX MEDICAL (US) 
  • INFUTRONIX SOLUTIONS LLC (US) 
  • BLUEWIND MEDICAL (US) 
  • NEURONANO (US) 
  • MICROTRANSPONDER (US) 

Pain Management Devices Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Pain Management Devices Market size was valued at around USD 12.76 billion in 2022 and is expected to rise from USD 15.50 billion in 2023 to reach a value of USD 73.7 billion by 2031, at a CAGR of 21.5% over the forecast period (2024–2031). 

To increase their market penetration, key vendors are continually engaged in the strategic efforts such as the technology innovation, partnerships, geographical expansion, and mergers and acquisitions. For instance, Medtronic announced the commercial introduction of the InterStim Micro Neurostimulator, a neurostimulator that has received FDA approval, in August 2020. The device was designed to aid patients in regaining reliable bladder and bowel control through sacral neuromodulation (SNM) therapy. 'MEDTRONIC (Ireland)  ', 'ABBOTT LABORATORIES (US) ', 'BOSTON SCIENTIFIC CORPORATION (US) ', 'STRYKER CORPORATION (US) ', 'Becton, Dickinson and Company (US) ', 'B. BRAUN MELSUNGEN AG (Germany) ', 'BAXTER INTERNATIONAL INC. (US) ', 'AVANOS MEDICAL, INC. (US) ', 'TELEFLEX, INC. (US) ', 'NIPRO CORPORATION (Japan) ', 'MOOG INC. (US) ', 'ATRICURE (US) ', 'NEVRO CORP. (US) ', 'MINDRAY MEDICAL INTERNATIONAL LIMITED (China) ', 'SHENZHEN MEDRENA BIOTECH CO., LTD. (China) ', 'EPIC MEDICAL (US) ', 'SOTERIX MEDICAL (US) ', 'INFUTRONIX SOLUTIONS LLC (US) ', 'BLUEWIND MEDICAL (US) ', 'NEURONANO (US) ', 'MICROTRANSPONDER (US) '

The high prevalence of chronic pain conditions, especially in the elderly population, is a major cause of pain management devices. Chronic pain, which can be caused by conditions such as arthritis, cancer, postoperative recovery obtaining results have become increasingly common, leading to a greater demand for effective pain management. The need for lengthy-time period pain remedy without the dependence on opioid medicines is pushing each patient and healthcare companies are searching for opportunity treatment options, thereby boosting the adoption of ache control devices. 

Shift Towards Non-Invasive Devices: A key trend in the pain management tool marketplace is the increasing call for non-invasive devices. Patients and healthcare specialists are choosing non-invasive methods inclusive of TENS and wearable ache control gadgets, which give powerful ache alleviation without the need for surgical procedure or implantable gadgets. These non-invasive techniques are gaining reputation because of their ease of use, low threat of complications and low fee as compared to invasive techniques. Since new devices with many implants are entering the market and offering a wide range of pain relief solutions to patients, this trend is expected to continue. 

North America accounted for the largest revenue share of 46.3% in 2022 due to advanced healthcare infrastructure facilitating access to cutting-edge pain management devices. Government policies and growing trends, such as Precision Medicine and the Affordable Care Act, along with well-planned reimbursement plan Facilities, growing elderly population, and high prevalence of stroke & hypertension. With the increasing number of older adults, the market is expected to show the significant growth as this population becomes more susceptible to chronic conditions. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Pain Management Devices Market

Report ID: SQMIG35A2502

$5,300
BUY NOW GET FREE SAMPLE